Testing the effect of metformin on breast cancer risk features
The purpose of this study is to see if taking metfomin can affect some of the risk factors associated with breast cancer, such as breast density, certain proteins and hormones, certain metabolites produced in the body, body weight, waist and hip sizes.
Primary disease category: Cancer
Secondary disease categories: Breast Cancer, Prevention
Sponsor: NCI/DCP
Projected enrollment dates: May 2014 to December 2019
Official study title: Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
External link(s):
UA Cancer Center Website
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/NCT02028221